Literature DB >> 10146995

Evaluation of pharmaceutical innovation: challenges and opportunities arising from the reforms to the national health service in the United Kingdom.

S St Leger1, K Rowsell, V Standing, A Haycox.   

Abstract

Mesh:

Year:  1992        PMID: 10146995     DOI: 10.2165/00019053-199201050-00002

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  3 in total

Review 1.  Quality of life instruments in the evaluation of new drugs.

Authors:  R Jaeschke; G H Guyatt; D Cook
Journal:  Pharmacoeconomics       Date:  1992-02       Impact factor: 4.981

2.  Procedures for evaluating innovatory proposals.

Authors:  A S St Leger; D Allen; R V Rowsell
Journal:  BMJ       Date:  1989-10-21

3.  Process and outcome in the National Health Service.

Authors:  M S Patel; A S St Leger; H Schnieden
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-09
  3 in total
  1 in total

1.  Interpreting economic evaluations of medicines: a new role for the pharmacist? .

Authors:  A T Denby; N E Wells
Journal:  Pharmacoeconomics       Date:  1992-08       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.